Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

QINLOCK 50 mg tablets {equilateral_black_triangle}

Active Ingredient:
ripretinib
Company:  
Deciphera See contact details
ATC code: 
L01EX19
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 08 Apr 2026

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Deciphera
Company image
Address
Strawinskylaan 3051, Amsterdam, 1077ZX, Netherlands
Medical Information e-mail
[email protected]
WWW
https://www.deciphera.com/
Medical Information Direct Line
+44 (0) 808 258 0026
Customer Care direct line
+44 (0) 1527 396 257
Stock Availability
[email protected]